Mon, September 12, 2011
Sun, September 11, 2011
Sat, September 10, 2011
Fri, September 9, 2011
Thu, September 8, 2011
Wed, September 7, 2011
Tue, September 6, 2011
Mon, September 5, 2011
Sun, September 4, 2011
Sat, September 3, 2011
Fri, September 2, 2011
Thu, September 1, 2011
Wed, August 31, 2011
Tue, August 30, 2011
[ Tue, Aug 30th 2011 ] - Market Wire
00 a.m. ET
Mon, August 29, 2011
Fri, August 26, 2011
Thu, August 25, 2011
Wed, August 24, 2011
Tue, August 23, 2011
Mon, August 22, 2011
Sat, August 20, 2011
Fri, August 19, 2011
Thu, August 18, 2011
Wed, August 17, 2011
[ Wed, Aug 17th 2011 ] - Market Wire
PPD???????BioDuro?????
Tue, August 16, 2011
Mon, August 15, 2011
Fri, August 12, 2011
Thu, August 11, 2011
Wed, August 10, 2011
Tue, August 9, 2011

Cyberonics to Participate in 2011 Baird Healthcare Conference


//health-fitness.news-articles.net/content/2011/ .. icipate-in-2011-baird-healthcare-conference.html
Published in Health and Fitness on Thursday, August 25th 2011 at 20:01 GMT by Market Wire   Print publication without navigation


Cyberonics to Participate in 2011 Baird Healthcare Conference -- HOUSTON, Aug. 25, 2011 /PRNewswire/ --

Cyberonics to Participate in 2011 Baird Healthcare Conference

[ ]

HOUSTON, Aug. 25, 2011 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: [ CYBX ]), a global leader in epilepsy management, today announced that it will participate in the 2011 Baird Healthcare Conference on Thursday, September 8, 2011, in New York.

Dan Moore, Cyberonics' President and Chief Executive Officer, will speak to the attendees of the conference at 2:15 PM Eastern Time.  A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at [ http://www.cyberonics.com ] on September 8, 2011.

About Cyberonics, Inc. and the VNS Therapy® System

Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation.  The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression.  The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve.  Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and the VNS Therapy System is available at [ www.cyberonics.com ].

Contact information
Greg Browne, CFO
Cyberonics, Inc.
100 Cyberonics Blvd.
Houston, TX 77058
Main:  (281) 228-7262
Fax:  (281) 218-9332
[ ir@cyberonics.com ]

SOURCE Cyberonics, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.cyberonics.com ]


Publication Contributing Sources